Borosil Scientific Ltd
Borosil Scientific Ltd (BOROSCI) last reported results for the quarter ended Jun 2026, with sales of ₹107 crore and net profit of ₹4.35 crore. The stock last traded at ₹115, a market capitalisation of ₹1,021 crore, on a P/E of 23.0. Over the past 52 weeks the stock has ranged between ₹96.6 and ₹181. Figures are as of 6 Oct 2026 and are not real time.
Borosil Scientific Ltd share price and key metrics
- Current price
- ₹115
- Market cap
- ₹1,021 cr
- Stock P/E
- 23.0
- Book value
- ₹49.6
- ROE
- 9.51%
- ROCE
- 12.1%
- Dividend yield
- 0.00%
- 52w high / low
- 181/96.6
Metrics as of 6 Oct 2026. Not real time.
Track Borosil Scientific Ltd
Cruxal reads every Borosil Scientific Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Borosil Scientific Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 85%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -20%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 8%
- Last Year
- 10%
Borosil Scientific Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹107 cr, up 11.2% from ₹95.98 cr a year earlier. Net profit turned positive at ₹4.35 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 103 | 101 | 129 | 95.98 | 107 | 121 | 143 | 107 |
| Expenses | 87.16 | 91.44 | 113 | 91.12 | 98.87 | 104 | 111 | 98.3 |
| Operating profit | 15.82 | 10.01 | 16.57 | 4.86 | 8.03 | 17.19 | 32.11 | 8.45 |
| OPM % | 15.36% | 9.87% | 12.80% | 5.06% | 7.51% | 14.17% | 22.43% | 7.92% |
| Other income | 1.58 | 1.86 | 2.59 | -3.69 | 2.15 | 0.5 | 2.06 | 2.67 |
| Interest | 0.36 | 0.35 | 0.44 | 0.38 | 0.23 | 0.26 | 0.26 | 0.25 |
| Depreciation | 4.63 | 4.58 | 4.7 | 4.88 | 4.81 | 4.79 | 4.76 | 4.89 |
| Profit before tax | 12.41 | 6.94 | 14.02 | -4.09 | 5.14 | 12.64 | 29.15 | 5.98 |
| Tax % | 29.09% | 38.33% | 38.52% | 3.18% | 44.36% | 31.25% | 6.52% | 27.09% |
| Net profit | 8.8 | 4.28 | 8.62 | -4.21 | 2.84 | 8.7 | 27.25 | 4.35 |
| EPS (₹) | 0.99 | 0.48 | 0.97 | -0.47 | 0.32 | 0.98 | 3.06 | 0.49 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Borosil Scientific Ltd annual results
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 392 | 434 | 462 | 478 |
| Operating profit | 47 | 53 | 63 | 66 |
| OPM % | 12% | 12% | 14% | 14% |
| Net profit | 23 | 27 | 35 | 43 |
| EPS (₹) | 2.65 | 3.01 | 3.89 | 4.85 |
TTM is the trailing twelve months to the most recent quarter.
Borosil Scientific Ltd balance sheet
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 9 | 9 | 9 |
| Reserves | 367 | 395 | 432 |
| Borrowings | 18 | 14 | 9 |
| Other liabilities | 95 | 86 | 90 |
| Total liabilities | 488 | 504 | 540 |
| Fixed assets | 192 | 187 | 189 |
| CWIP | 1 | 1 | 9 |
| Investments | 0 | 105 | 122 |
| Other assets | 295 | 210 | 220 |
| Total assets | 488 | 504 | 540 |
As reported by the company. Total assets equal total liabilities by construction.
Borosil Scientific Ltd cash flow
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operations | 30 | 120 | 43 |
| Cash from investing | -2 | -115 | -37 |
| Cash from financing | -16 | -3 | -6 |
| Net cash flow | 12 | 1 | -0 |
| Free cash flow | 17 | 106 | 16 |
| CFO / operating profit | 97% | 249% | 92% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Borosil Scientific Ltd operating ratios
| Per year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | — | 10% | 12% |
| Debtor days | 57 | 59 | 60 |
| Inventory days | 244 | 218 | 226 |
| Days payable | 102 | 79 | 93 |
| Cash conversion cycle | 200 | 199 | 193 |
| Working capital days | 165 | 86 | 84 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Borosil Scientific Ltd shareholding pattern
Promoters held 68.27% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.23% and DIIs 0.26%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.86% | 67.84% | 67.81% | 67.80% | 67.80% | 67.80% | 68.08% | 68.27% |
| FIIs | 0.37% | 0.27% | 0.24% | 0.20% | 0.07% | 0.07% | 0.09% | 0.23% |
| DIIs | 0.01% | 0.02% | 0.02% | 0.05% | 0.10% | 0.19% | 0.26% | 0.26% |
| Public | 31.74% | 31.88% | 31.91% | 31.93% | 32.03% | 31.93% | 31.57% | 31.22% |
| No. of shareholders | 61,201 | 60,373 | 58,894 | 58,178 | 57,586 | 56,297 | 55,319 | 53,712 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Borosil Scientific Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Please find enclosed the Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations…
Read the full analysis - Intimation for Closure of Trading WindowInsider Trading / SASTlow impact
- Borosil Scientific Limited secures shareholder approval for fundraising and ESOP implementation at 35th AGMAGM/EGMmedium impact
Cruxal's analysis: Borosil Scientific Limited has successfully concluded its 35th Annual General Meeting…
Read the full analysis - Borosil Scientific Limited Announces AGM Proceedings Including Proposals for Fund Raising and ESOP ImplementationAGM/EGMmedium impact
Cruxal's analysis: Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, to…
Read the full analysis - Borosil Scientific Limited announces resignation of Senior Management PersonnelCompany Updatelow impact
Cruxal's analysis: Borosil Scientific Limited has informed the exchanges that Mr. Kailash Motwani, Head of…
Read the full analysis - Borosil Scientific Announces Significant Capacity Expansion of 93 Lakh Units to Meet Rising Demand from Borosil LimitedOthershigh impact
Cruxal's analysis: Borosil Scientific Limited has approved a major capacity expansion at its Bharuch…
Read the full analysis - Borosil Scientific Ltd announces capacity addition under Regulation 30Company Updatemedium impact
Cruxal's analysis: Borosil Scientific Ltd has issued an intimation regarding capacity addition in compliance…
Read the full analysis - Borosil Scientific Ltd announces electronic dispatch of Annual Report for FY 2025-26 and 35th AGM noticeCompany Updatelow impact
Cruxal's analysis: Borosil Scientific Ltd has completed the electronic dispatch of its Annual Report for the…
Read the full analysis - Borosil Scientific Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Borosil Scientific Ltd has filed its Annual Report for the financial year 2025-26, dated…
Read the full analysis - Borosil Scientific Ltd issues web-link for FY 2025-26 Annual ReportCompany Updatelow impact
Cruxal's analysis: Borosil Scientific Ltd has issued a formal intimation regarding the availability of its…
Read the full analysis - Borosil Scientific Limited Announces FY 2025-26 Annual Report and 35th AGM NoticeAGM/EGMmedium impact
Cruxal's analysis: Borosil Scientific Limited has released its Annual Report for FY 2025-26, reporting…
Read the full analysis - Borosil Scientific Ltd announces 35th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Borosil Scientific Ltd has issued a newspaper advertisement regarding the scheduling of…
Read the full analysis - Borosil Scientific Limited schedules 35th Annual General Meeting for September 25, 2026AGM/EGMlow impact
Cruxal's analysis: Borosil Scientific Limited has formally announced its 35th Annual General Meeting (AGM)…
Read the full analysis - Borosil Scientific Ltd allots 4,475 equity shares under ESOP schemeCompany Updatelow impact
Cruxal's analysis: Borosil Scientific Ltd has announced the allotment of 4,475 equity shares following the…
Read the full analysis - Borosil Scientific Limited Q1FY27 Investor Presentation Highlights Growth Strategy and Financial PerformanceCompany Updatemedium impact
Cruxal's analysis: Borosil Scientific Limited released its Q1FY27 investor presentation, reporting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.